ATC Group: C01D Vasodilators used in cardiac diseases

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of C01D in the ATC hierarchy

Level Code Title
1 C Cardiovascular system
2 C01 Cardiac therapy
3 C01D Vasodilators used in cardiac diseases

Group C01D contents

Code Title
C01DA Organic nitrates
C01DB Quinolone vasodilators
C01DX Other vasodilators used in cardiac diseases

Active ingredients in C01D

Active Ingredient Description
Dilazep
Glyceryl trinitrate

Glyceryl trinitrate is a vasodilator and is used for angina of effort. Vasodilation is achieved by the releasing of free redical nitric oxide which activates guanylate cyclase and increases synthesis of guanosine 3′ and 5′-monophosphate with resultant effects on the phosphorylation of proteins in smooth muscle. If taken in excess, its vasodilatory effect can cause headache.

Heptaminol
Isosorbide dinitrate

Isosorbide dinitrate is an organic nitrate, which in common with other cardioactive nitrates, is a vasodilator.

Isosorbide mononitrate

Isosorbide mononitrate is an organic nitrate, which, in common with other cardioactive nitrates, is a vasodilator. It produces decreased left and right ventricular end-diastolic pressures to a greater extent than the decrease in systemic arterial pressure, thereby reducing afterload and especially the preload of the heart.

Molsidomine

Molsidomine is a long acting vasodilating drug. Molsidomine, a sydnonimine acting as a heterocyclic direct nitric oxide donor, has been used for the treatment of patients with stable angina pectoris. It’s also established drug for the treatment of coronary heart disease. Molsidomine is metabolized in the liver to the active metabolite linsidomine. Linsidomine is an unstable compound that releases nitric oxide (NO) upon decay as the actual vasodilating compound.

Nicorandil

Nicorandil is a derivative of the niacinamide that is structurally combined with an organic nitrate. It provides a dual mode of action leading to relaxation of vascular smooth muscle. Nicorandil is a potassium-channel opener that causes vasodilatation of arterioles and large coronary arteries. Its nitrate-like properties produce venous vasodilation through stimulation of guanylate cyclase. Nicorandil has a direct effect on coronary arteries without leading to a steal phenomenon. The overall action improves blood flow to post-stenotic regions and the oxygen balance in the myocardium.

Pentaerithrityl tetranitrate
Propatylnitrate
Trapidil
Vericiguat

Vericiguat is a stimulator of soluble guanylate cyclase (sGC). Heart failure is associated with impaired synthesis of nitric oxide (NO) and decreased activity of its receptor, sGC. The pharmacodynamic effects of vericiguat are consistent with the mode of action of a sGC stimulator resulting in smooth muscle relaxation and vasodilation.

Related product monographs

Title Information Source Document Type  
CARMIL XL Prolonged release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CEDOCARD Solution for infusion Υπουργείο Υγείας (CY) MPI, EU: SmPC
DEPONIT Transdermal patch Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DERMATRANS Transdermal patch Health Products Regulatory Authority (IE) MPI, EU: SmPC
ELANTAN LA Prolonged release capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
GLYTRIN Sublingual spray, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
IKOREL Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ISMO Retard prolonged-release tablet Medicines and Medical Devices Safety Authority (NZ) MPI, EU: SmPC
ISOKET 1 mg/ml Concentrate for solution for injection / infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ISOKET RETARD Prolonged release tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ISOKET Solution for infusion or injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ISOMONIT Prolonged release tablet Health Products Regulatory Authority (IE) MPI, EU: SmPC
ISORDIL TITRADOSE Tablet FDA, National Drug Code (US) MPI, US: SPL/Old
ISOSORBIDE MONONITRATE / CARMIL / MONOMIL Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MONOREM Prolonged-release tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
MONOREM Tablet Υπουργείο Υγείας (CY) MPI, EU: SmPC
NITRO-DUR Transdermal patch FDA, National Drug Code (US) MPI, US: SPL/Old
NITROCINE Solution for infusion Health Products Regulatory Authority (IE) MPI, EU: SmPC
NITRODERM TTS Transdermal patch Υπουργείο Υγείας (CY) MPI, EU: SmPC
NITROLINGUAL Sublingual spray Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NITRONAL Solution for infusion Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NYZAMAC Prolonged-release capsule, hard Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
RECTOGESIC Rectal ointment Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
TRANSIDERM NITRO Transdermal patch Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
VERQUVO Film-coated tablet European Medicines Agency (EU) MPI, EU: SmPC